Role of stromal-derived cytokines and growth factors in bone metastasis

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

BACKGROUND. Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. Bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when activated during osteoclastic bone resorption, can enhance the growth of tumor cells. METHODS. This article reviews the role these factors may play in bone metastasis, RESULTS. Several studies have shown that breast carcinoma cells, which induce osteoclastic bone resorption, release growth factors that enhance tumor growth. In addition, bone-derived growth factors and chemokines, such as stromal cellderived factor 1 and monocyte chemoattractant protein 1, can act as chemoattractants to attract tumor cells to bone. Finally, the interaction between tumor cells and bone marrow stromal cells can result in increased production of cytokines and growth factors, such as interleukin 6 or the ligand for the receptor activator of nuclear factor κB, that can enhance bone destruction, tumor growth, and angiogenesis. CONCLUSIONS. Stromal cell-derived cytokines and growth factors as well as growth factors that are released during the bone resorption process play a critical role in the development of bone metastasis. Interruption of this symbiotic relation between tumors that induce bone destruction and release of bone-derived growth factors can have beneficial effects on blocking both bone destruction and decreasing tumor burden within bone.

Original languageEnglish (US)
Pages (from-to)733-738
Number of pages6
JournalCancer
Volume97
Issue number3 SUPPL.
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Intercellular Signaling Peptides and Proteins
Cytokines
Neoplasm Metastasis
Bone and Bones
Bone Development
Neoplasms
Bone Resorption
Stromal Cells
Growth
Chemokine CCL2
Chemotactic Factors
Cytoplasmic and Nuclear Receptors
Tumor Burden
Osteoblasts
Mesenchymal Stromal Cells
Chemokines
Interleukin-6
Bone Marrow
Breast Neoplasms
Ligands

Keywords

  • Adhesive interactions
  • Bone metastases
  • Chemokines
  • Cytokines
  • Growth factors
  • Osteoblasts
  • Osteoclasts
  • Stromal cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Role of stromal-derived cytokines and growth factors in bone metastasis. / Roodman, G. David.

In: Cancer, Vol. 97, No. 3 SUPPL., 01.02.2003, p. 733-738.

Research output: Contribution to journalArticle

@article{8ea2ca7757914c82b901b332635a8be2,
title = "Role of stromal-derived cytokines and growth factors in bone metastasis",
abstract = "BACKGROUND. Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. Bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when activated during osteoclastic bone resorption, can enhance the growth of tumor cells. METHODS. This article reviews the role these factors may play in bone metastasis, RESULTS. Several studies have shown that breast carcinoma cells, which induce osteoclastic bone resorption, release growth factors that enhance tumor growth. In addition, bone-derived growth factors and chemokines, such as stromal cellderived factor 1 and monocyte chemoattractant protein 1, can act as chemoattractants to attract tumor cells to bone. Finally, the interaction between tumor cells and bone marrow stromal cells can result in increased production of cytokines and growth factors, such as interleukin 6 or the ligand for the receptor activator of nuclear factor κB, that can enhance bone destruction, tumor growth, and angiogenesis. CONCLUSIONS. Stromal cell-derived cytokines and growth factors as well as growth factors that are released during the bone resorption process play a critical role in the development of bone metastasis. Interruption of this symbiotic relation between tumors that induce bone destruction and release of bone-derived growth factors can have beneficial effects on blocking both bone destruction and decreasing tumor burden within bone.",
keywords = "Adhesive interactions, Bone metastases, Chemokines, Cytokines, Growth factors, Osteoblasts, Osteoclasts, Stromal cells",
author = "Roodman, {G. David}",
year = "2003",
month = "2",
day = "1",
language = "English (US)",
volume = "97",
pages = "733--738",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Role of stromal-derived cytokines and growth factors in bone metastasis

AU - Roodman, G. David

PY - 2003/2/1

Y1 - 2003/2/1

N2 - BACKGROUND. Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. Bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when activated during osteoclastic bone resorption, can enhance the growth of tumor cells. METHODS. This article reviews the role these factors may play in bone metastasis, RESULTS. Several studies have shown that breast carcinoma cells, which induce osteoclastic bone resorption, release growth factors that enhance tumor growth. In addition, bone-derived growth factors and chemokines, such as stromal cellderived factor 1 and monocyte chemoattractant protein 1, can act as chemoattractants to attract tumor cells to bone. Finally, the interaction between tumor cells and bone marrow stromal cells can result in increased production of cytokines and growth factors, such as interleukin 6 or the ligand for the receptor activator of nuclear factor κB, that can enhance bone destruction, tumor growth, and angiogenesis. CONCLUSIONS. Stromal cell-derived cytokines and growth factors as well as growth factors that are released during the bone resorption process play a critical role in the development of bone metastasis. Interruption of this symbiotic relation between tumors that induce bone destruction and release of bone-derived growth factors can have beneficial effects on blocking both bone destruction and decreasing tumor burden within bone.

AB - BACKGROUND. Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. Bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when activated during osteoclastic bone resorption, can enhance the growth of tumor cells. METHODS. This article reviews the role these factors may play in bone metastasis, RESULTS. Several studies have shown that breast carcinoma cells, which induce osteoclastic bone resorption, release growth factors that enhance tumor growth. In addition, bone-derived growth factors and chemokines, such as stromal cellderived factor 1 and monocyte chemoattractant protein 1, can act as chemoattractants to attract tumor cells to bone. Finally, the interaction between tumor cells and bone marrow stromal cells can result in increased production of cytokines and growth factors, such as interleukin 6 or the ligand for the receptor activator of nuclear factor κB, that can enhance bone destruction, tumor growth, and angiogenesis. CONCLUSIONS. Stromal cell-derived cytokines and growth factors as well as growth factors that are released during the bone resorption process play a critical role in the development of bone metastasis. Interruption of this symbiotic relation between tumors that induce bone destruction and release of bone-derived growth factors can have beneficial effects on blocking both bone destruction and decreasing tumor burden within bone.

KW - Adhesive interactions

KW - Bone metastases

KW - Chemokines

KW - Cytokines

KW - Growth factors

KW - Osteoblasts

KW - Osteoclasts

KW - Stromal cells

UR - http://www.scopus.com/inward/record.url?scp=0037304016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037304016&partnerID=8YFLogxK

M3 - Article

C2 - 12548570

AN - SCOPUS:0037304016

VL - 97

SP - 733

EP - 738

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3 SUPPL.

ER -